Any Clinical Benefit From the Use of Oncofoetal Markers in the Management of Chemotherapy for Patients with Metastatic Colorectal Carcinomas?
| Autor: | Trillet-Lenoir, V. ∗, †, ∗, Chapuis, F. ‡, Touzet, S. ‡, Barbier, J.Y. ∗, Freyer, G. ∗, †, Gaudin, J.L. §, Lombard-Bohas, C. ∥, Valette, P.J. ∥, Lledo, G. ¶, Gouttebel, M.C. ∗∗, Boyer, J.D. ††, Chassignol, L. ‡‡, Hamon, H. §§, Claudel-Bonvoisin, S. ∗, Leprince, E. ∥∥, Amoyal, P. ¶¶, Glehen, O. ∗, †, Darnand, P. ∗, Heilmann, M.O. ∗, Bleuse, J.P. ∗∗∗ |
|---|---|
| Zdroj: | In Clinical Oncology 2004 16(3):196-203 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect